Mr. Kurosaki is the Chief Financial Oﬃcer at Synchronicity Pharma. Mr. Kurosaki also consults for a number of early-stage venture backed life science companies in areas of financial reporting, accounting and operations. Previously, he was the Vice President, Finance & Administration at MacuSight, a developer for the treatment of serious ocular diseases. While at MacuSight, Mr. Kurosaki managed the ﬁnancial and general operational aspects of the Company and played a key ﬁnancial role in a license collaboration agreement with a publicly traded ophthalmology company.
Prior to MacuSight, Mr. Kurosaki served as Director of Finance at Oculex Pharmaceuticals, which was acquired by Allergan in 2003 and ultimately marketed Ozurdex®, a biodegradable implant that has received regulatory approval in the US and abroad. Mr. Kurosaki also served as an audit manager at PwC and is an active Certiﬁed Public Accountant in California.
Mr. Kurosaki received his B.S. in Business Administration from the University of California at Berkeley.